Regeneron CEO 23andMe Bid

News

23andMe, Regeneron

Regeneron CEO on 23andMe bid: Trying to balance individual privacy with biotech & genetics research

Regeneron founder, chairman and CEO Dr. Leonard Schleifer joins 'Squawk Box' to discuss the company's bid for 23andMe, privacy concerns over 23andMe's genetic data, importance of biotechnology, and more.

BioSpace · 1d

Regeneron Backs Off 23andMe, Losing Bid to Former CEO

Regeneron did not bid higher on the genetic testing company because of “its assessment of 23andMe’s remaining value,” according to a spokesperson for the pharma.

pharmaphorum · 1d

Former CEO wins bidding war for 23andMe, beating Regeneron

23andMe's co-founder and former chief executive, Anne Wojcicki, looks set to regain control of the business after emerging victorious in a bidding war for the bankrupt company.

12don MSN

Fate of 23andMe genetic data still not settled amid bankruptcy fight

Me is proposing to reopen its bankruptcy auction to entertain a final offer from a nonprofit operated by its co-founder, ...

20hon MSN

Anne Wojcicki's bid to buy back 23andMe may not end legal fight over DNA customer data

Anne Wojcicki's winning bid to reclaim control of 23andMe doesn't necessarily end the fight over what happens to the DNA of 15 million people collected by the bankrupt consumer genomics company.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

News

23andMe, Regeneron

Trending now